16 results on '"Kathryn E. Saatman"'
Search Results
2. Peer‐induced cocaine seeking in rats: Comparison to nonsocial stimuli and role of paraventricular hypothalamic oxytocin neurons
- Author
-
Lindsey R. Hammerslag, Bree A. Humburg, Samantha G. Malone, Joshua S. Beckmann, Kathryn E. Saatman, Valery Grinevich, and Michael T. Bardo
- Subjects
Male ,Neurons ,Pharmacology ,Medicine (miscellaneous) ,Self Administration ,Oxytocin ,Extinction, Psychological ,Rats ,Cocaine-Related Disorders ,Psychiatry and Mental health ,Cocaine ,Animals ,Female ,Cues ,Clozapine ,Paraventricular Hypothalamic Nucleus - Abstract
The purpose of this study was to determine if social vs nonsocial cues (peer vs light/tone) can serve as discriminative stimuli to reinstate cocaine seeking. In addition, to assess a potential mechanism, an oxytocin (OT) promoter-linked hM3Dq DREADD was infused into the paraventricular nucleus of the hypothalamus to determine whether peer-induced cocaine seeking is decreased by activation of OT neurons. Male rats underwent twice-daily self-administration sessions, once with cocaine in the presence of one peer (S+) and once with saline in the presence of a different peer (S-). Another experiment used similar procedures, except the discriminative stimuli were nonsocial (constant vs flashing light/tone), with one stimulus paired with cocaine (S+) and the other paired with saline (S-). A third experiment injected male and female rats with OTp-hM3Dq DREADD or control virus into PVN and tested them for peer-induced reinstatement of cocaine seeking following clozapine (0.1 mg/kg). Although acquisition of cocaine self-administration was similar in rats trained with either peer or light/tone discriminative stimuli, the latency to first response was reduced by the peer S+, but not by the light/tone S+. In addition, the effect of the conditioned stimulus was overshadowed by the peer S+ but not by the light/tone S+. Clozapine blocked the effect of the peer S+ in rats receiving the OTp-hM3Dq DREADD virus, but not in rats receiving the control virus. These results demonstrate that a social peer can serve as potent trigger for drug seeking and that OT in PVN modulates peer-induced reinstatement of cocaine seeking.
- Published
- 2022
3. Speckle contrast diffuse correlation tomography of cerebral blood flow in perinatal disease model of neonatal piglets
- Author
-
Kathryn E. Saatman, Qiang Cheng, Guoqiang Yu, Mehrana Mohtasebi, Lei Chen, Chong Huang, and Siavash Mazdeyasna
- Subjects
medicine.medical_specialty ,Swine ,media_common.quotation_subject ,Ischemia ,General Physics and Astronomy ,01 natural sciences ,Article ,General Biochemistry, Genetics and Molecular Biology ,Brain Ischemia ,010309 optics ,Imaging, Three-Dimensional ,Internal medicine ,Intensive care ,0103 physical sciences ,Animals ,Humans ,Medicine ,Contrast (vision) ,General Materials Science ,media_common ,Asphyxia ,business.industry ,010401 analytical chemistry ,General Engineering ,Brain ,General Chemistry ,medicine.disease ,0104 chemical sciences ,medicine.anatomical_structure ,Intraventricular hemorrhage ,Cerebral blood flow ,Cerebrovascular Circulation ,Scalp ,Cardiology ,Tomography ,medicine.symptom ,Tomography, X-Ray Computed ,business - Abstract
We adapted and tested an innovative noncontact speckle contrast diffuse correlation tomography (scDCT) system for 3D imaging of cerebral blood flow (CBF) variations in perinatal disease models utilizing neonatal piglets, which closely resemble human neonates. CBF variations were concurrently measured by the scDCT and an established diffuse correlation spectroscopy (DCS) during global ischemia, intraventricular hemorrhage, and asphyxia; significant correlations were observed. Moreover, CBF variations associated reasonably with vital pathophysiological changes. In contrast to DCS measurements of mixed signals from local scalp, skull and brain, scDCT generates 3D images of CBF distributions at prescribed depths within the head, thus enabling specific determination of regional cerebral ischemia. With further optimization and validation in animals and human neonates, scDCT has the potential to be a noninvasive imaging tool for both basic neuroscience research in laboratories and clinical applications in neonatal intensive care units.
- Published
- 2021
4. Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia
- Author
-
Nirmal Verma, Han Ly, Miao Liu, Florin Despa, Peter T. Nelson, Larry B. Goldstein, Kathryn E. Saatman, John T. Slevin, Geert Jan Biessels, and Fengen Wu
- Subjects
0301 basic medicine ,endocrine system ,medicine.medical_specialty ,endocrine system diseases ,Endothelium ,medicine.medical_treatment ,Amylin ,macromolecular substances ,Type 2 diabetes ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Diabetes mellitus ,medicine ,Endothelial dysfunction ,business.industry ,Insulin ,Human brain ,medicine.disease ,Endothelial stem cell ,030104 developmental biology ,Endocrinology ,medicine.anatomical_structure ,Neurology ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
Objective The brain blood vessels of patients with type 2 diabetes and dementia have deposition of amylin, an amyloidogenic hormone cosecreted with insulin. It is not known whether vascular amylin deposition is a consequence or a trigger of vascular injury. We tested the hypothesis that the vascular amylin deposits cause endothelial dysfunction and microvascular injury and are modulated by amylin transport in the brain via plasma apolipoproteins. Methods Rats overexpressing amyloidogenic (human) amylin in the pancreas (HIP rats) and amylin knockout (AKO) rats intravenously infused with aggregated amylin were used for in vivo phenotyping. We also carried out biochemical analyses of human brain tissues and studied the effects of the aggregated amylin on endothelial cells ex vivo. Results Amylin deposition in brain blood vessels is associated with vessel wall disruption and abnormal surrounding neuropil in patients with type 2 diabetes and dementia, in HIP rats, and in AKO rats infused with aggregated amylin. HIP rats have brain microhemorrhages, white matter injury, and neurologic deficits. Vascular amylin deposition provokes loss of endothelial cell coverage and tight junctions. Intravenous infusion in AKO rats of human amylin, or combined human amylin and apolipoprotein E4, showed that amylin binds to plasma apolipoproteins. The intravenous infusion of apolipoprotein E4 exacerbated the brain accumulation of aggregated amylin and vascular pathology in HIP rats. Interpretation These data identify vascular amylin deposition as a trigger of brain endothelial dysfunction that is modulated by plasma apolipoproteins and represents a potential therapeutic target in diabetes-associated dementia and stroke. Ann Neurol 2017;82:208–222
- Published
- 2017
5. Insulin‐like Growth Factor‐1 Treatment of Experimental Traumatic Brain Injury Increases Newborn Neuron Migration Through the Granular Cell Layer
- Author
-
Binoy Joseph, Anthony J. DeSana, Kathryn E. Saatman, and Ryan Crump
- Subjects
Chemistry ,Traumatic brain injury ,medicine.medical_treatment ,medicine.disease ,Biochemistry ,Cell biology ,Insulin-like growth factor ,Granular cell ,Genetics ,medicine ,Neuron migration ,Molecular Biology ,Layer (electronics) ,Biotechnology - Published
- 2020
6. [P1–204]: POST‐INJURY PERK INHIBITION IN MOUSE MODEL OF TAUOPATHY
- Author
-
Shelby E. Meier, Chiara Lanzillotta, Kathryn E. Saatman, Sara Galvis, Bret N. Smith, Joe F. Abisambra, and Jeff Boychuk
- Subjects
Pathology ,medicine.medical_specialty ,Epidemiology ,business.industry ,Health Policy ,medicine.disease ,Post injury ,Psychiatry and Mental health ,Cellular and Molecular Neuroscience ,Developmental Neuroscience ,medicine ,Neurology (clinical) ,Tauopathy ,Geriatrics and Gerontology ,business - Published
- 2017
7. Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouse
- Author
-
Jifeng Bian, Kathryn E. Saatman, Kathleen M. Schoch, Catherine R. von Reyn, Glenn C. Telling, and David F. Meaney
- Subjects
Male ,Genetically modified mouse ,Proteases ,Prions ,Proteolysis ,Mice, Transgenic ,Nerve Tissue Proteins ,Hippocampus ,Biochemistry ,Article ,Mice ,Cellular and Molecular Neuroscience ,Mediator ,Calcium-binding protein ,medicine ,Animals ,Humans ,Promoter Regions, Genetic ,Calpastatin ,NAV1.2 Voltage-Gated Sodium Channel ,medicine.diagnostic_test ,biology ,Calcium-Binding Proteins ,Neurodegeneration ,Spectrin ,Calpain ,medicine.disease ,Founder Effect ,Cell biology ,Brain Injuries ,Nerve Degeneration ,biology.protein ,Intercellular Signaling Peptides and Proteins ,Female ,Neuroscience - Abstract
The calpain family of calcium-dependent proteases has been implicated in a variety of diseases and neurodegenerative pathologies. Prolonged activation of calpains results in proteolysis of numerous cellular substrates including cytoskeletal components and membrane receptors, contributing to cell demise despite coincident expression of calpastatin, the specific inhibitor of calpains. Pharmacological and gene-knockout strategies have targeted calpains to determine their contribution to neurodegenerative pathology; however, limitations associated with treatment paradigms, drug specificity, and genetic disruptions have produced inconsistent results and complicated interpretation. Specific, targeted calpain inhibition achieved by enhancing endogenous calpastatin levels offers unique advantages in studying pathological calpain activation. We have characterized a novel calpastatin-overexpressing transgenic mouse model, demonstrating a substantial increase in calpastatin expression within nervous system and peripheral tissues and associated reduction in protease activity. Experimental activation of calpains via traumatic brain injury resulted in cleavage of α-spectrin, collapsin response mediator protein-2, and voltage-gated sodium channel, critical proteins for the maintenance of neuronal structure and function. Calpastatin overexpression significantly attenuated calpain-mediated proteolysis of these selected substrates acutely following severe controlled cortical impact injury, but with no effect on acute hippocampal neurodegeneration. Augmenting calpastatin levels may be an effective method for calpain inhibition in traumatic brain injury and neurodegenerative disorders.
- Published
- 2013
8. P3‐127: Perk Inhibition in Controlled Cortical Impact Model of Traumatic Brain Injury
- Author
-
Shelby E. Meier, Jeff Boychuk, Bret N. Smith, Joe F. Abisambra, Emily Miller, and Kathryn E. Saatman
- Subjects
Epidemiology ,business.industry ,Traumatic brain injury ,Health Policy ,medicine.disease ,Psychiatry and Mental health ,Cellular and Molecular Neuroscience ,Developmental Neuroscience ,Anesthesia ,Impact model ,Medicine ,Neurology (clinical) ,Geriatrics and Gerontology ,business ,Neuroscience - Published
- 2016
9. DNase I disinhibition is predominantly associated with actin hyperpolymerization after traumatic brain injury
- Author
-
Florence M. Bareyre, Ramesh Raghupathi, Kathryn E. Saatman, and Tracy K. McIntosh
- Subjects
Cellular and Molecular Neuroscience ,Traumatic brain injury ,Disinhibition ,business.industry ,medicine ,medicine.symptom ,medicine.disease ,business ,Biochemistry ,Neuroscience ,Actin - Published
- 2008
10. Rin GTPase deficiency promotes neuroprotection following traumatic brain injury
- Author
-
Kathryn E. Saatman, Shaun W. Carlson, Jennifer M. Brelsfoard, Erica Littlejohn, Megan Pannell, Travis Stewart, Douglas A. Andres, and Weikang Cai
- Subjects
Traumatic brain injury ,business.industry ,Genetics ,medicine ,GTPase ,medicine.disease ,business ,Molecular Biology ,Biochemistry ,Neuroprotection ,Neuroscience ,Biotechnology - Published
- 2015
11. Alterations in Ionized and Total Blood Magnesium After Experimental Traumatic Brain Injury
- Author
-
Kathryn E. Saatman, Adrienne L. Brown, Grant Sinson, Justin D. Weisser, Tracy K. McIntosh, Mark A. Helfaer, and Florence M. Bareyre
- Subjects
Male ,Cations, Divalent ,Traumatic brain injury ,Magnesium Chloride ,Poison control ,chemistry.chemical_element ,Motor Activity ,Calcium ,Nervous System ,Biochemistry ,Neuroprotection ,Rats, Sprague-Dawley ,Cellular and Molecular Neuroscience ,Cognition ,Blood plasma ,medicine ,Animals ,Learning ,Magnesium ,Calcium metabolism ,business.industry ,Head injury ,medicine.disease ,Rats ,chemistry ,Brain Injuries ,Anesthesia ,Nervous System Diseases ,business - Abstract
Experimental evidence suggests that magnesium plays a role in the pathophysiological sequelae of brain injury. The present study examined the variation of blood ionized and total magnesium, as well as potassium, sodium, and ionized calcium, after experimental fluid percussion brain injury in rats. Blood ionized magnesium concentration significantly declined from 0.45 +/- 0.02 to 0.32 +/- 0.02 mM by 30 min postinjury and stayed depressed for the 24-h study period in vehicle-treated rats. Blood total magnesium concentration was 0.59 +/- 0.01 mM and remained stable over time in brain-injured vehicle-treated animals. When magnesium chloride (125 micromol/rat) was administered 1 h postinjury, ionized magnesium levels were restored by 2 h postinjury and remained at normal values up to 24 h following brain trauma. Magnesium treatment also significantly reduced posttraumatic neuromotor impairments 1 and 2 weeks after the insult, but failed to attenuate spatial learning deficits. A significant positive and linear correlation could be established between ionized magnesium levels measured 24 h postinjury and neuromotor outcome at 1 and 2 weeks. We conclude that acute ionized magnesium measurement may be a predictor of long-term neurobehavioral outcome following head injury and that delayed administration of magnesium chloride can restore blood magnesium concentration and attenuate neurological motor deficits in brain-injured rats.
- Published
- 2002
12. Regional and Temporal Alterations in DNA Fragmentation Factor (DFF)-Like Proteins Following Experimental Brain Trauma in the Rat
- Author
-
Kathryn E. Saatman, Tracy K. McIntosh, Chen Zhang, Michelle C. LaPlaca, and Ramesh Raghupathi
- Subjects
Male ,Programmed cell death ,medicine.medical_specialty ,Pathology ,Time Factors ,Traumatic brain injury ,Protein subunit ,Apoptosis ,DNA Fragmentation ,Biology ,Hippocampus ,Biochemistry ,Functional Laterality ,Rats, Sprague-Dawley ,Cellular and Molecular Neuroscience ,Cytosol ,Internal medicine ,medicine ,Animals ,Poly-ADP-Ribose Binding Proteins ,Cell Nucleus ,Cerebral Cortex ,Deoxyribonucleases ,Brain ,Proteins ,medicine.disease ,Rats ,Endocrinology ,medicine.anatomical_structure ,Organ Specificity ,Brain Injuries ,DNA fragmentation ,Apoptosis Regulatory Proteins ,Nucleus ,Intracellular - Abstract
DNA fragmentation, an early event in neuronal death following traumatic brain injury, may be triggered by the 40-kDa subunit of DNA fragmentation factor (DFF40). DFF40 is typically bound to the 45-kDa subunit of DFF (DFF45), and activation of DFF40 may occur as a result of caspase-3-mediated cleavage of DFF45 into 30- and 11-kDa fragments. In this study, the intracellular distribution of DFF45 and DFF40 was examined following lateral fluid percussion brain injury of moderate severity (2.4-2.7 atm) in male Sprague-Dawley rats. In the cytosolic fraction (S1) of the injured cortex at 2 and 24 h postinjury, significant decreases in the intensities of DFF45-like proteins at 45- and 32-kDa bands and a concomitant increase in the 11-kDa bands were observed (p < 0.05 vs. uninjured controls). A significant decrease in the intensities of the 32-kDa band in the nuclear (P1) fraction of the injured cortex was observed at 30 min and 2 h postinjury (p < 0.01). Concomitantly, a decrease in DFF40 was observed in the cortical S1 fraction at 2 and 24 h (p < 0.05) and in the P1 fraction at 30 min and 2 h postinjury (p < 0.01). In the hippocampus, DFF45 decreased at 30 min in the P1 and 2 h in the S1 fraction (p < 0.05) and recovered by 24 h postinjury, whereas DFF40 was significantly decreased in the S1 and increased in the P1 fraction at both 2 and 24 h (p < 0.01), which indicated a translocation of DFF40 from cytosol to nucleus. These data are the first to demonstrate that changes in DFF proteins occur after brain trauma and suggest that these changes may play a role in apoptotic cell death via caspase-3-DFF45/DFF40-DNA cleavage observed following traumatic brain injury.
- Published
- 2002
13. Overexpression of Bcl-2 is neuroprotective after experimental brain injury in transgenic mice
- Author
-
Tracy K. McIntosh, Ramesh Raghupathi, Diane E. Merry, Kathryn E. Saatman, Michio Nakamura, and Uwe Scherbel
- Subjects
Genetically modified mouse ,Pathology ,medicine.medical_specialty ,Glial fibrillary acidic protein ,Traumatic brain injury ,General Neuroscience ,Dentate gyrus ,Hippocampus ,Morris water navigation task ,Biology ,Hippocampal formation ,medicine.disease ,Neuroprotection ,medicine ,biology.protein - Abstract
The cell death regulatory protein, Bcl-2, has been suggested to participate in the pathophysiology of various neurological disorders, including traumatic brain injury (TBI). The cognitive function and histopathologic sequelae after controlled cortical impact brain injury were evaluated in transgenic (TG) mice that overexpress human Bcl-2 protein (n = 13) and their wild type (WT) controls (n = 9). Although brain-injured Bcl-2 TG mice exhibited similar posttraumatic deficits in a Morris water maze (MWM) test of spatial memory as their WT counterparts at 1 week postinjury, the preinjury learning ability of Bcl-2 TG mice was impaired significantly compared with their WT littermates (P < 0.05). In contrast, histopathologic analysis revealed significantly attenuated tissue loss in the ipsilateral hemisphere (p < 0.01) and decreased tissue loss in ipsilateral hippocampal area CA3 (P < 0.001) and the dentate gyrus (P < 0.01) in brain-injured Bcl-2 TG mice compared with brain-injured WT mice. Immunohistochemical evaluation of glial fibrillary acidic protein also revealed a significant decrease in reactive astrocytosis in the ipsilateral dorsal thalamus (P < 0.05) and the ventral thalamus (P < 0.01) in brain-injured Bcl-2 TG mice. These results suggest that overexpression of Bcl-2 protein may play a protective role in neuropathologic sequelae after TBI. J. Comp. Neurol. 412:681–692, 1999. © 1999 Wiley-Liss, Inc.
- Published
- 1999
14. Traumatic brain injury in young, amyloid‐β peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Aβ deposition during aging
- Author
-
Takaomi C. Saido, Jesse A. Berlin, Michio Nakamura, Virginia M.-Y. Lee, Marie L. Schmidt, Douglas H. Smith, Kathryn E. Saatman, James A. Clemens, Ramesh Raghupathi, Tracy K. McIntosh, John Q. Trojanowski, Yasushi Nakagawa, and Amaris Rodrı́guez
- Subjects
Genetically modified mouse ,Cingulate cortex ,Pathology ,medicine.medical_specialty ,Amyloid beta ,Traumatic brain injury ,General Neuroscience ,Growth factor ,medicine.medical_treatment ,Wild type ,Hippocampus ,Biology ,medicine.disease ,nervous system diseases ,Toxicity ,biology.protein ,medicine - Abstract
Traumatic brain injury (TBI) is an epigenetic risk factor for Alzheimer's disease (AD). To test the hypothesis that TBI contributes to the onset and/or progression of AD-like β-amyloid peptide (Aβ) deposits, we studied the long-term effects of TBI in transgenic mice that overexpress human Aβ from a mutant Aβ precursor protein (APP) minigene driven by a platelet derived (PD) growth factor promoter (PDAPP mice). TBI was induced in 4-month-old PDAPP and wild type (WT) mice by controlled cortical impact (CCI). Because Aβ begins to deposit progressively in the PDAPP brain by 6 months, we examined WT and PDAPP mice at 2, 5, and 8 months after TBI or sham treatment (i.e., at 6, 9, and 12 months of age). Hippocampal atrophy in the PDAPP mice was more severe ipsilateral versus contralateral to TBI, and immunohistochemical studies with antibodies to different Aβ peptides demonstrated a statistically significant reduction in hippocampus and cingulate cortex Aβ deposits ipsilateral versus contralateral to CCI in 9–12 month-old PDAPP mice. Hippocampal atrophy and reduced Aβ deposits were not seen in hippocampus or cingulate cortex of sham-injured PDAPP mice or in any WT mice. These data suggest that the vulnerability of brain cells to Aβ toxicity increases and that the accumulation of Aβ deposits decrease in the penumbra of CCI months after TBI. Thus, in addition to providing unique opportunities for elucidating genetic mechanisms of AD, transgenic mice that recapitulate AD pathology also may be relevant animal models for investigating the poorly understood role that TBI and other epigenetic risk factors play in the onset and/or progression of AD. J. Comp. Neurol. 411:390–398, 1999. © 1999 Wiley-Liss, Inc.
- Published
- 1999
15. Riluzole attenuates cortical lesion size, but not hippocampal neuronal loss, following traumatic brain injury in the rat
- Author
-
Florence Wahl, Jean-Marie Stutzmann, Kathryn E. Saatman, Tracy K. McIntosh, Ramesh Raghupathi, Chen Zhang, and Douglas H. Smith
- Subjects
Sodium channel activity ,Traumatic brain injury ,business.industry ,Glutamate receptor ,Excitotoxicity ,Pharmacology ,Hippocampal formation ,medicine.disease ,medicine.disease_cause ,Neuroprotection ,Riluzole ,Cellular and Molecular Neuroscience ,Cresyl violet ,chemistry.chemical_compound ,chemistry ,Anesthesia ,medicine ,business ,medicine.drug - Abstract
The neuroprotective effects of Riluzole, a compound with several mechanisms of action including the inhibition of sodium channel activity and glutamate release, were evaluated in a rat model of parasagittal fluid-percussion (FP) brain injury. Male Sprague-Dawley rats (350-400 g, n = 17) were anesthetized with sodium pentobarbital (60 mg/kg i.p.) and subjected to parasagittal FP brain injury of moderate severity (2.3-2.5 atm). Fifteen min following injury, animals randomly received an i.v. bolus of either Riluzole (8 mg/kg, n = 8) or vehicle (n = 9), followed by subcutaneous injections (identical dose) at 6 hr and 24 hr. Two weeks after injury and drug treatment, animals were sacrificed and a series of brain sections, stained with Hematoxylin and Eosin (H&E) or cresyl violet, were evaluated for quantitative cortical lesion volume and cell counts of hippocampal CA3 neurons, respectively, using a computerized image analysis system. Administration of Riluzole significantly reduced FP-induced tissue loss in the temporal/occipital cortices ipsilateral to the site of impact by 46%, compared to vehicle-treated, brain-injured animals (P = 0.01). In contrast, the selective neuronal loss observed in the CA3 region of the ipsilateral hippocampus was unaffected by Riluzole treatment. The present study demonstrates that Riluzole can attenuate cortical lesion size following brain trauma. These neuroprotective effects may be related to the synergy of the different mechanisms of action of Riluzole.
- Published
- 1998
16. Twofold overexpression of human ?-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury
- Author
-
Kathryn E. Saatman, Hisayuki Murai, Steven G. Younkin, John Q. Trojanowski, Douglas H. Smith, Chris Eckman, Jean E.S. Pierce, Tracy K. McIntosh, Virginia M.-Y. Lee, Jeanne F. Loring, and Ramesh Raghupathi
- Subjects
medicine.medical_specialty ,Pathology ,Glial fibrillary acidic protein ,biology ,Traumatic brain injury ,General Neuroscience ,Morris water navigation task ,Neuropathology ,Hippocampal formation ,medicine.disease ,Neuroprotection ,Astrogliosis ,Endocrinology ,Internal medicine ,mental disorders ,medicine ,biology.protein ,Amyloid precursor protein - Abstract
By using transgenic mice that overexpress human beta-amyloid precursor proteins (APPs) at levels twofold higher than endogenous APPs, following introduction of the human APP gene in a yeast artificial chromosome (YAC), we examined the effects of controlled cortical impact (CCI) brain injury on neuromotor/cognitive dysfunction and the development of Alzheimer's disease (AD)-like neuropathology. Neuropathological analyses included Nissl-staining and immunohistochemistry to detect APPs, beta-amyloid (Abeta), neurofilament proteins, and glial fibrillary acidic protein, whereas Abeta levels were measured in brain homogenates from mice subjected to CCI and control mice by using a sensitive sandwich enzyme-linked immunosorbent assay. Twenty APP-YAC transgenic mice and 17 wild type (WT) littermate controls were anesthetized and subjected to CCI (velocity, 5 m/second; deformation depth, 1 mm). Sham (anesthetized but uninjured) controls (n = 10 APP-YAC; n = 8 WT) also were studied. Motor function was evaluated by using rotarod, inclined-plane, and forelimb/hindlimb flexion tests. The Morris water maze was used to assess memory. Although CCI induced significant motor dysfunction and cognitive deficits, no differences were observed between brain-injured APP-YAC mice and WT mice at 24 hours and 1 week postinjury. By 1 week postinjury, both cortical and hippocampal CA3 neuron loss as well as extensive astrogliosis were observed in all injured animals, suggesting that overexpression of human APPs exhibited no neuroprotective effects. Although AD-like pathology (including amyloid plaques) was not observed in either sham or brain-inj ured animals, a significant decrease in brain concentrations of only Abeta terminating at amino acid 40 (Abeta x-40) was observed following brain injury in APP-YAC mice (P < 0.05 compared with sham control levels). Our data show that the APP-YAC mice do not develop AD-like neuropathology following traumatic brain injury. This may be because this injury does not induce elevated levels of the more amyloidogenic forms of human Abeta (i.e., Abeta x-42/43) in these mice.
- Published
- 1998
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.